-transparent.png){kind=logo}
Ursolic acid (UA) and oleanolic acid (OA), which had been isolated from Glechoma hederacea as inhibitors of Epstein-Barr virus (EBV) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), were tested against inhibitory effect on tumor promotion by TPA in vivo. They inhibited effectively the tumor promotion in mouse skin and the activities were comparable to that of a known inhibitor of tumor promotion, retinoic acid (RA). Interestingly, UA was more effective on a single application before initial TPA-treatment than on a continuous application before each TPA-treatment, while OA and RA were ineffective in the same treatment. These data suggest that the role of UA for inhibitory action on tumor promotion differs slightly from those of RA and OA.
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
September 2015,
Cancer prevention research (Philadelphia, Pa.),
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
February 1993,
Cancer letters,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
March 1990,
Chemical & pharmaceutical bulletin,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
September 1998,
Toxicological sciences : an official journal of the Society of Toxicology,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
March 1994,
Biological & pharmaceutical bulletin,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
November 1988,
Cancer research,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
February 2014,
Food & function,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
November 2002,
Biological & pharmaceutical bulletin,
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
July 2011,
Cancer prevention research (Philadelphia, Pa.),
H Tokuda, and
H Ohigashi, and
K Koshimizu, and
Y Ito
January 2007,
Biological & pharmaceutical bulletin,
